Tumor molecular age acceleration is associated with early progression in diffuse large B-cell lymphoma

Leukemia · Published 2026-07-27 · DOI 10.1038/s41375-026-03076-0

Authors (16)

Jiahao Chen, Yan Zhu, Zi-Yang Shi, Xiang Li, Yun-Ruei Kao, Di Fu, Zi-Hui Lu, Fan Zhang, Jia-Yin He, Yan Zhao, Hao-Xing Bian, Qing Shi, Li Wang, Shu Cheng, Peng-Peng Xu, Wei-Li Zhao

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Chen, J., Zhu, Y., Shi, Z., et al. (2026). Tumor molecular age acceleration is associated with early progression in diffuse large B-cell lymphoma. Leukemia. https://doi.org/10.1038/s41375-026-03076-0

Related articles

• Evolutionary considerations for risk stratification in TP53-variant myeloproliferative neoplasms · Leukemia · 2026 · Same journal
• Rbm5 sustains leukemia stem cells through a Myc-driven transcriptional circuitry · Leukemia · 2026 · Same journal
• Cohesin haploinsufficiency and inv(16) cooperate to reinforce Fli1 gene transcriptional programs during acute myeloid leukemia initiation and maintenance · Leukemia · 2026 · Same journal
• Non-invasive multiparametric characterization of essential thrombocythemia, premyelofibrosis, and overt myelofibrosis · Leukemia · 2026 · Same journal
• FATP2-mediated lipid metabolism enhances chimeric antigen receptor T-cell therapy resistance in B-cell acute lymphoblastic leukemia · Leukemia · 2026 · Same journal
• IKZF1N159S is associated with adverse outcomes in patients with myelodysplastic neoplasms · Leukemia · 2026 · Same journal
• Prognostic impact of measurable residual disease in AML patients treated frontline with azacitidine and venetoclax: results from the French VENAURA registry · Leukemia · 2026 · Same journal
• Randomized phase 2 trial of CPX-351 vs. CLAG-M (cladribine, cytarabine, G-CSF, and mitoxantrone) for medically unfit adults with acute myeloid leukemia or other high-grade myeloid neoplasms · Leukemia · 2026 · Same journal
• Stuck in traffic: CART cells targeting the tumor microenvironment in hematological malignancies, current advances and future perspectives · Leukemia · 2026 · Same journal
• Unpacking the epigenetic landscape of acute lymphoblastic leukemia: resolving cellular heterogeneity and nutritional complexities · Leukemia · 2026 · Same journal